MARKET

ONTXW

ONCONOVA THERAPE
ONTXW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0309
3.592
0.0285
-
ONCONOVA THERAPEUTICS INC - TRAWS WILL BE LED BY INCOMING CHIEF EXECUTIVE OFFICER, WERNER CAUTREELS
Reuters · 04/02 11:00
Onconova Therapeutics Inc <ONTX.OQ> expected to post a loss of 25 cents a share - Earnings Preview
Onconova Therapeutics Inc expected to post a loss of 25 cents a share. The company is expected to report a 16.7% increase in quarterly revenue to $65.33 thousand. The mean analyst estimate for Onconova's quarterly revenue is for a 25 cents a share loss.
Reuters · 03/15 20:27
Onconova Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Reuters · 08/10/2023 21:02
BRIEF-Onconova Therapeutics Reports First Quarter 2023 Financial Results And Provides Business Update
Reuters · 05/15/2023 21:45
BRIEF-Onconova Therapeutics Doses First Patient In Phase 1/2a Trial Of Narazaciclib Combined With Letrozole In Endometrial Cancer
Reuters · 05/11/2023 12:59

Webull offers ONCONOVA THERAPE stock information, including NASDAQ: ONTXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONTXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONTXW stock methods without spending real money on the virtual paper trading platform.